By Editor , 23 September 2026
Apollo-Backed Forge to Acquire Becker's Healthcare from Pamlico Capital

New York – September 22, 2026 -- Forge, the B2B events and media company backed by Apollo, has agreed to acquire Becker's Healthcare from Pamlico Capital, adding a platform that reaches more than 1.5 million healthcare leaders and executives.

Becker's Healthcare brings a 15,000-attendee live events network to the deal

Chicago-based Becker's Healthcare hosts more than 15,000 attendees annually across its live events, serving hospital, health system and healthcare executives through digital products, executive communities and conferences.

By Editor , 23 September 2026
Anonymous Donor Gives $100M to Princess Margaret Cancer Foundation

Toronto – September 22, 2026 -- The Princess Margaret Cancer Foundation has secured a $100 million gift from an anonymous donor, the largest single donation in the foundation's history and the largest cancer-related gift ever recorded in Canada.

By Editor , 23 September 2026
Aflac Delivers Robotic Ducks to Pediatric Cancer Patients in St. Louis

St. Louis – September 22, 2026 -- Aflac Incorporated brought its My Special Aflac Duck robotic companion to pediatric cancer and sickle cell disease patients at SSM Health Cardinal Glennon Children's Hospital, part of a program that has distributed nearly 50,000 units free of charge since 2018 across the U.S., Japan and Northern Ireland.

By Editor , 23 September 2026

Washington – September 22, 2026 -- Danaher Corporation (NYSE: DHR) will hold its third-quarter 2026 earnings conference call on Wednesday, October 21, 2026, at 8:00 a.m. ET, the company confirmed.

Danaher to webcast hour-long Q3 results discussion on October 21

The call, lasting approximately one hour, will be webcast via the "Investors" section of Danaher's website under "Events & Presentations," alongside a slide presentation. Investors can dial in at 800-267-6316 within the U.S. or +1 203-518-9783 outside the U.S., using Conference ID DHRQ326.

By Editor , 23 September 2026

Mexico City – September 22, 2026 -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) has filed a Notice of Rights with the Bolsa Mexicana de Valores declaring a cash dividend of $0.20 Mexican pesos per common share, totaling $200,000,000.00 pesos based on shares currently outstanding.

By Editor , 23 September 2026
MediKarma's AI Health Score Hits 90.6% Correlation With Claims Costs

San Ramon, Calif. – September 22, 2026 -- MediKarma, Inc. reported that its proprietary health score achieved a 90.6% correlation with actual claims costs within an 8 million-patient cohort, as the company positions its JackTM and JillTM AI infrastructure as the clinical backbone for direct-to-patient healthcare offerings.

By Editor , 23 September 2026
AAAAI Pushes Penicillin Allergy De-Labeling as 90% of Patients Cleared

Milwaukee – September 22, 2026 -- More than 90% of patients carrying a documented penicillin allergy in their electronic medical records can safely take the drug after clinical evaluation, according to the American Academy of Allergy, Asthma & Immunology (AAAAI), which is marking National Penicillin Allergy Day on September 28 with a push for wider adoption of allergy "de-labeling" protocols.

By Editor , 23 September 2026
Lateral Flow Assay Market to Reach $16.37B by 2031, Grows 8.2%

Sheridan, Wyoming – – September 22, 2026 -- The global lateral flow assay market is set to expand from $11.04 billion in 2026 to $16.37 billion by 2031, a compound annual growth rate of 8.2%, according to a new study by Wissen Research.

By Editor , 22 September 2026
ROMTech Targets VA Rural Care Gap With Home Rehab Data

Brookfield, Conn. – September 22, 2026 -- ROM Technologies Inc. (ROMTech) said its PortableConnect Rehab System can address two structural barriers facing Department of Veterans Affairs knee-replacement patients: distance from rehabilitation sites and fractured coordination between VA and Community Care providers.

By Editor , 22 September 2026
BRIJ Medical Study: Zero Complications in 100 Orthopedic Cases

San Diego – September 22, 2026 -- BRIJ Medical reported zero documented cases of wound dehiscence, infection, allergic dermatitis, adhesive-related skin injury or wound-related reoperation across a 100-case retrospective study of its Brijjit Force-Modulating Tissue Bridges in sports medicine incision management.